Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: A single-center analysis of 47 patients

International Journal of Hematology

Volumn 92, Issue 2, 2010, Pages 334-341

  Yokoyama, Hiroki ^a   Mori, Shin Ichiro ^a   Kobayashi, Yukio ^a   Kurosawa, Saiko ^a   Saito, Bungo ^a   Fuji, Shigeo ^a   Maruyama, Dai ^a   Azuma, Teruhisa ^a   Kim, Sung Won ^a   Watanabe, Takashi ^a   Tanosaki, Ryuji ^a   Tobinai, Kensei ^a   Takaue, Yoichi ^a   Fukuda, Takahiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Acute leukemia; Therapy related myelodysplastic syndrome; Transplantation

Indexed keywords

ANTHRACYCLINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; FLUDARABINE; METHOTREXATE; NITROSOUREA DERIVATIVE; PROCARBAZINE; TACROLIMUS;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; COMORBIDITY; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 77956894757     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0640-7     Document Type: Article

References (35)

1. JO Armitage PP Carbone JM Connors A Levine JM Bennett S Kroll 2003 Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients J Clin Oncol 21 897 906 10.1200/JCO.2003.07.113 12610191 (Pubitemid 46613489)
2. G Leone L Pagano D Ben-Yehuda MT Voso 2007 Therapy-related leukemia and myelodysplasia: susceptibility and incidence Haematologica 92 1389 1398 10.3324/haematol.11034 17768113 1:CAS:528:DC%2BD2sXht12rurjN (Pubitemid 350144157)
3. A Josting S Wiedenmann J Franklin M May M Sieber J Wolf, et al. 2003 Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group J Clin Oncol 21 3440 3446 10.1200/JCO.2003.07.160 12668650 (Pubitemid 46594076)
4. W Kern T Haferlach S Schnittger W Hiddemann C Schoch 2004 Prognosis in therapy-related acute myeloid leukemia and impact of karyotype J Clin Oncol 22 2510 2511 10.1200/JCO.2004.99.301 15197216 (Pubitemid 41115412)
5. EH Estey 1998 Prognosis and therapy of secondary myelodysplastic syndromes Haematologica 83 543 549 9676028 1:STN:280:DyaK1czktVKkuw%3D%3D
6. C Schoch W Kern S Schnittger W Hiddemann T Haferlach 2004 Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML Leukemia 18 120 125 10.1038/sj.leu.2403187 14586477 1:STN:280:DC%2BD3srpslCrsQ%3D%3D (Pubitemid 38159447)
7. H Kantarjian S O'Brien J Cortes F Giles S Faderl E Jabbour, et al. 2006 Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome Cancer 106 1090 1098 10.1002/cncr.21723 16435386
8. SM Smith MM Le Beau D Huo T Karrison RM Sobecks J Anastasi, et al. 2003 Clinical-cytogenetic association in 306 patients with therapy-related myelodysplasia and myeloid leukaemia: the University of Chicago series Blood 102 43 52 10.1182/blood-2002-11-3343 12623843 1:CAS:528:DC%2BD3sXltFemtLg%3D (Pubitemid 36759634)
9. N Mauritzson M Albin L Rylander R Billström T Ahlgren Z Mikoczy, et al. 2002 Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001 Leukemia 16 2366 2378 10.1038/sj.leu.2402713 12454741 1:CAS:528:DC%2BD38XovFKkur8%3D (Pubitemid 36067289)
10. JE Anderson TA Gooley G Schoch C Anasetti WI Bensinger RA Clift, et al. 1997 Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy Blood 89 2578 2585 9116305 1:CAS:528:DyaK2sXitVyktbo%3D
11. KK Ballen DG Gilliland EC Guinan CC Hsieh SK Parsons IJ Rimm, et al. 1997 Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia Bone Marrow Transplant 20 737 743 10.1038/sj.bmt.1700971 9384475 1:STN:280:DyaK1c%2FksVWgsw%3D%3D
12. I Yakoub-Agha P de La Salmonière P Ribaud L Sutton E Wattel M Kuentz, et al. 2000 Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation J Clin Oncol 18 963 971 10694545 1:STN:280:DC%2BD3c7mtVOguw%3D%3D
13. RP Witherspoon HJ Deeg B Storer C Anasetti R Storb FR Appelbaum 2001 Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia J Clin Oncol 19 2134 2141 11304765 1:STN:280: DC%2BD3M3mtFOisA%3D%3D
14. N Kröger R Brand A van Biezen A Zander J Dierlamm D Niederwieser, et al. 2009 Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation Haematologica 94 542 549 10.3324/haematol.2008.000927 19278968
15. C Chang BE Storer BL Scott EM Bryant HM Shulman ME Flowers, et al. 2007 Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders Blood 110 1379 1387 10.1182/blood-2007-02- 076307 17488876 1:CAS:528:DC%2BD2sXptFKlsLo%3D (Pubitemid 47281440)
16. P Armand HT Kim DJ DeAngelo VT Ho CS Cutler RM Stone, et al. 2007 Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation Biol Blood Marrow Transplant 13 655 664 10.1016/j.bbmt.2007.01.079 17531775 1:CAS:528:DC%2BD2sXntl2ksr8%3D (Pubitemid 46767993)
17. NL Harris BS Jaffe J Diebold G Flandrin HK Muller-Hermelink J Vardiman, et al. 1999 World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997 J Clin Oncol 17 3835 3849 10577857 1:STN:280:DC%2BD3c%2FksVyltQ%3D%3D
18. ML Slovak KJ Kopecky PA Cassileth DH Harrington KS Theil A Mohamed, et al. 2000 Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study Blood 96 4075 4083 11110676 1:CAS:528:DC%2BD3cXosl2hsbo%3D
19. H Glucksberg R Storb A Fefer CD Buckner PE Neiman RA Clift, et al. 1974 Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation 18 295 304 10.1097/00007890-197410000-00001 4153799 1:STN:280:DyaE2M%2Fis1Wjsw%3D%3D
20. D Przepiorka D Weisdorf P Martin HG Klingemann P Beatty J Hows, et al. 1995 1994 Consensus conference on acute GVHD grading Bone Marrow Transplant 15 825 828 7581076 1:STN:280:DyaK28%2Fot1Ojtw%3D%3D
21. KM Sullivan E Agura C Anasetti F Appelbaum C Badger S Bearman, et al. 1991 Chronic graft-versus-host disease and other late complications of bone marrow transplantation Semin Hematol 28 250 259 1887253 1:STN:280: DyaK3MzmtFWjug%3D%3D
22. BD Cheson JM Bennett KJ Kopecky T Büchner CL Willman EH Estey, et al. 2003 Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia J Clin Oncol 21 4642 4649 10.1200/JCO.2003.04.036 14673054 (Pubitemid 46594039)
23. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
24. B Saito T Fukuda H Yokoyama S Kurosawa T Takahashi S Fuji, et al. 2008 Impact of T-cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen Biol Blood Marrow Transplant 14 1148 1155 10.1016/j.bbmt.2008.07.013 18804045 1:CAS:528:DC%2BD1cXht1KlurbL
25. D Maruyama T Fukuda R Kato S Yamasaki E Usui Y Morita-Hoshi, et al. 2007 Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen Biol Blood Marrow Transplant 13 932 941 10.1016/j.bbmt.2007.04.004 17640597 (Pubitemid 47055387)
26. L Pagana A Pulsoni ME Tosti G Avvisati L Mele M Mele, et al. 2001 Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia Br J Haematol 112 109 117 10.1046/j.1365-2141.2001.02527.x 11225603 1:STN:280:DC%2BD3M7ltFansw%3D%3D (Pubitemid 32151158)
27. JM Rowe 2002 Therapy of secondary leukemia Leukemia 16 748 750 10.1038/sj.leu.2402456 11960361 1:STN:280:DC%2BD383it1aiug%3D%3D
28. B Quesnel H Kantarjian JP Bjergaard P Brault E Estey JL Lai, et al. 1993 Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature J Clin Oncol 11 2370 2379 8246025 1:STN:280:DyaK2c%2FmsFylug%3D%3D
29. ML Slovak V Bedell L Popplewell DA Arber C Schoch R Slater 2002 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop Genes Chromosomes Cancer 33 379 394 10.1002/gcc.10042 11921272 (Pubitemid 34208799)
30. HM Kantarjian MJ Keating RS Walters TL Smith A Cork KB McCredie, et al. 1986 Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features J Clin Oncol 4 1748 1757 3783201 1:STN:280:DyaL2s%2FlvF2msw%3D%3D
31. ZN Singh D Huo J Anastasi SM Smith T Karrison MM Le Beau, et al. 2007 Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant Am J Clin Pathol 127 197 205 10.1309/NQ3PMV4U8YV39JWJ 17210514 (Pubitemid 46797176)
32. M Beaumont M Sanz PM Carli F Maloisel X Thomas L Detourmignies, et al. 2003 Therapy-related acute promyelocytic leukemia J Clin Oncol 21 2123 2137 10.1200/JCO.2003.09.072 12775738 1:CAS:528:DC%2BD2cXpsVGqtbs%3D (Pubitemid 46606361)
33. A Pulsoni L Pagano F Lo Coco G Avvisati L Mele E Di Bona, et al. 2002 Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience Blood 100 1972 1976 10.1182/blood-2001-12-0312 12200354 1:CAS:528:DC%2BD38Xnt1yiu7c%3D (Pubitemid 35001225)
34. TJ Nevill DE Hogge CL Toze SH Nantel MM Power YR Abou Mourad, et al. 2008 Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML Bone Marrow Transplant 42 659 666 10.1038/bmt.2008.226 18679372 1:STN:280:DC%2BD1cjnvF2ltA%3D%3D
35. CR Hake TA Graubert TS Fenske 2007 Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients? Bone Marrow Transplant 39 59 70 10.1038/sj.bmt.1705547 17143301 1:STN:280: DC%2BD2s%2Fhs1Ojug%3D%3D (Pubitemid 46085225)